Complete response of hepatocellular carcinoma with sorafenib and (90)Y radioembolization

Advanced hepatocellular carcinoma has a dismal prognosis, with a median overall survival of 7.9 months if untreated and of 10.7 months if treated with sorafenib. We present a case of advanced previously unresectable hepatocellular carcinoma in a 49-year-old man that achieved a pathologic complete re...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chaudhury, P.K., Hassanain, M., Bouteaud, J.M., Alcindor, T., Nudo, C.G., Valenti, D., Cabrera, T., Kavan, P., Feteih, I., Metrakos, P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2010
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949375/
https://ncbi.nlm.nih.gov/pubmed/20975882
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky